Suchergebnisse - "Martinez-Rebollar, M"

PubPharm (16)

1

Observational cohort study of rilpivirine (RPV) utilization in Europe

enthalten in: AIDS research and therapy | 2022

von Cozzi-Lepri, A. | Peters, L. | Pelchen-Matthews, A. | +122

2

Network meta-analysis of post-exposure prophylaxis randomized clinical trials

enthalten in: HIV medicine | 2021

von Fernández, I. | de Lazzari, E. | Inciarte, A. | +41

3

Subclinical cardiovascular disease in patients starting contemporary protease inhibitors

enthalten in: HIV medicine | 2018

von González-Cordón, A. | Doménech, M. | Camafort, M. | +10

4

Direct-acting antivirals for hepatitis C virus induce a rapid clinical and biochemical remission of porphyria cutanea tarda

enthalten in: The British journal of dermatology | 2017

von Combalia, A. | To-Figueras, J. | Laguno, M. | +2

5

Tenofovir disoproxil fumarate/emtricitabine plus ritonavir-boosted lopinavir or cobicistat-boosted elvitegravir as a single-tablet regimen for HIV post-exposure prophylaxis

enthalten in: The Journal of antimicrobial chemotherapy | 2017

von Inciarte, A. | Leal, L. | González, E. | +38

6

Direct‐acting antivirals for hepatitis C virus induce a rapid clinical and biochemical remission of porphyria cutanea tarda

enthalten in: The British journal of dermatology | 2017

von Combalia, A. | To‐Figueras, J. | Laguno, M. | +2

7

Direct‐acting antivirals for hepatitis C virus induce a rapid clinical and biochemical remission of porphyria cutanea tarda

enthalten in: British Journal of Dermatology | 2017

von Combalia, A. | To‐Figueras, J. | Laguno, M. | +2

8

Boceprevir plus pegylated interferon/ribavirin to re-treat hepatitis C virus genotype 1 in HIV-HCV co-infected patients : final results of the Spanish BOC HIV-HCV Study

enthalten in: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases | 2016

von Laguno, M. | Von Wichmann, M. | Van den Eynde, E. | +19

9

Improvement of BMD after Switching from Lopinavir/R Plus Two Nucleos(T)ide Reverse Transcriptase Inhibitors to Lopinavir/R Plus Lamivudine : OLE-LIP Substudy

enthalten in: HIV clinical trials | 2016

von Crespo, M. | Navarro, J. | Martinez-Rebollar, M. | +8

10

Improvement of BMD after Switching from Lopinavir/R Plus Two Nucleos(T)ide Reverse Transcriptase Inhibitors to Lopinavir/R Plus Lamivudine: OLE-LIP Substudy

enthalten in: HIV clinical trials | 2016

von Crespo, M. | Navarro, J. | Martinez-Rebollar, M. | +8